StockData
Nasus Pharma Ltd logo

Nasus Pharma Ltd (NSRX) stock

NSRXNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 25, 2026Score 6/30
$2.61−0.05 (-1.88%)

Close on Nov 17, 2026Market cap $23.53MP/E –Yield –

Nasus Pharma price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Nasus Pharma's price to sales ratio was 0.0× on Nov 11, 2026.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.0×–

More Nasus Pharma figures

See a number that looks wrong?